|
|
2005 |
|
|
|
| Publication | Author Affiliation | Website
| PDF | | Tian Q, Li J, Xie X, Sun M, Sang H, Zhou C, An T, Hu L, Ye RD, and Wang MW. (2005) Stereospecific Induction of Nuclear Factor- B Activation by Isochamaejasmin. Mol. Pharmacol., 68: 1534 - 1542 | National Center for Drug Screening, China | Link | | | Doshna CM, Shen AC, Gebhard DF, Brees DJ, and Somps CJ. (2005) Investigating Markers of DNA Oxidation, Lipid Peroxidation and Stress Response in Human Lens Epithelial Cell Lines. Invest. Ophthalmol. Vis. Sci., 46: 3850. | Pfizer Global Research and Development | Link | | | Pece-Barbara N, Vera S, Kathirkamathamby K, Liebner S, Di Guglielmo GM, Dejana E, Wrana JL, and Letarte M. (2005) Endoglin Null Endothelial Cells Proliferate Faster and Are More Responsive to Transforming Growth Factor 1 with Higher Affinity Receptors and an Activated Alk1 Pathway. J. Biol. Chem., 280: 27800 - 27808. | Mount Sinai Hospital, University of Toronto and University of Milan | Link | | | Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P, Leist M. (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci. Jul 6;25(27):6329-42. | Department of Disease Biology, H. Lundbeck A/S | Link | | | Vogt A, Tamewitz A, Skoko J, Sikorski RP, Giuliano KA, Lazo JS. (2005) The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem. May 13;280(19):19078-86. | University of Pittsburgh | Link | | | Kerrison JB, Lewis RN, Otteson DC, Zack DJ. (2005) Bone morphogenetic proteins promote neurite outgrowth in retinal ganglion cells. Mol Vis. Mar 18;11:208-15. | Johns Hopkins University School of Medicine | Link | | Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G. (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.Nat Med. Jan;11(1):90-4.
| National Research Institute for Child Health and Development, Japan | | | | Bova MP, Tam D, McMahon G, Mattson MN.(2005). Troglitazone induces a rapid drop of mitochondrial membrane potential in liver HepG2 cells. Toxicology Letters.(155) 2005 | Sugen | | | Ilyin SE, Horowitz D, Belkowski SM, Xin H, Eckardt AJ, Darrow AL, Chen C, Maley D, D'Andrea M, Plata-Salaman CR, Derian CK (2005). Integrated expressional analysis: application to the drug discovery process.
Methods. 37(3):280-8. | Johnson & Johnson | | | | Giuliano KA, WS Cheung, DP Curran, BW Day, AJ Kassick, JS Lazo, SG Nelson, Y Shin, DL Taylor (2005) Systems Cell Biology Knowledge Created from High Content Screening. Assay Drug Dev Technol. 3:501-514 | Cellumen, University of Pittsburgh, Carnegie Mellon University | | | | Morelock MM, EA Hunter, TJ Moran, S Heynen, C Laris, M Thieleking, M Akong, I Mikic, S Callaway, RP DeLeon, A Goodacre, D Zacharias, JH Price (2005) Statistics of Assay Validation in High Throughput Cell Imaging of Nuclear Factor κB Nuclear Translocation. Assay Drug Dev Technol. 3:483-499. | Boehringer Ingelheim | | | | Vasudevan C, N Fursov, P Maunder, M Cong, M Federici, JR Haskins, T Livelli, Z Zhong (2005) Improving High-Content-Screening Assay Performance by Using Division-Arrested Cells. Assay Drug Dev Technol. 3:515-523. | Cellomics, Inc., Cell & Molecular Technologies, Inc. | | | | Bertelsen M and A Sanfridson (2005) Inflammatory Pathway Analysis Using a High Content Screening Platform. Assay Drug Dev Technol. 3:261-271. | AstraZeneca, Lund | | | | Lovborg H, J Gullbo, R Larsson (2005) Screening for apoptosis-classical and emerging techniques. Anticancer Drugs 16:593-9. | Uppsala Univeristy | | | | Ghosh RN, R DeBiasio, CC Hudson, ER Ramer, CL Cowan, RH Oakley.(2005) Quantitative Cell-Based High-Content Screening for Vasopressin Receptor Agonists Using Transfluor Technology. J Biomol Screen. Aug.10(5):476-84 . | Cellomics, Inc, Norak Biosciences, Inc. | | | Borchert KM, Galvin RJ, Frolik CA, Hale LV, DL Halladay, RJ Gonyier, OJ Trask, DR Nickischer, KA Houck. (2005) High-content screening assay for activators of the wnt/fzd pathway in primary human cells. Assay Drug Dev Technol. (2):133-41.
| Lilly Research Laboratories, Eli Lilly & Co. | | | Grace MJ, Lee S, Bradshaw S, Chapman J, Spond J, Cox S, Delorenzo M, Brassard D,
Wylie D, Cannon-Carlson S, Cullen C, Indelicato S, Voloch M, Bordens R (2005) Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT
signaling pathway. J Biol Chem. 280:6327-36. | Schering-Plough Research Institute | | |
Back to top
|
|
|
Home 
HCS Library 
top